Valuations - Everyone should keep in mind that while valuations are nice they are about as successful as the typical biotech company. Just a few examples:
Dew - Genr - He made money but out side of him and the GENR board few other did. IDIX - Was a buy at $12, still is at $3. IMCL was a buy a $5, a sell at $30, went to $86. GTCB was a buy at $3 and a sell at .30.
David - YMI, I could go on but Dew handles that enough already.
BI - Gives more knowledge then a properly worded google query was convincing everyone to sell IMCL at $5.
I have own every stock listed here. Made money on YMI, IMCL, MNTA, and GTCB. I could name all of my failures but the list is to long and no one listens to me here anyway.
The point I would make to all the lurkers is that this is the best biotech board in the land, but if MNTA goes from $10, to $5, to ... they take the money out of your account, not the knowledge sharing posters on this board.
R
Market Data 
Markets 
AI
